Jin Young Jung

This inventor holds 6 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Lg Chem, Ltd, Trinno Technology Co., Ltd., Trinno Technology Co., Ltd.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin Young Jung. Retrieved from https://idiyas.com/inventor/jin-young-jung-r7onby93

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 11)

% Patents Active = 83.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 5.9

ph-index = 1

Company Filing History:

Trinno Technology Co., Ltd.

patents

1 out of 1

Trinno Technology Co., Ltd.

patent

Years Active: 2024-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12765025 - Silicon carbide power semiconductor device having uniform channel length and manufacturing method thereof (2026-10-13),

2. 12637440 - Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof (2026-05-26),

3. 12630528 - NOVEL AMINO ARYL DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR AND USE THEREOF (2026-05-19),

4. 12501636 - Power semiconductor device capable of controlling slope of current and voltage during dynamic switching (2025-12-16),

5. 12459915 - Biaryl derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof (2025-11-04),

6. 12087848 - Power semiconductor device with reduced loss and manufacturing method the same (2024-09-10),

Title: Jin Young Jung: Innovator in Pharmaceutical Chemistry

Introduction

Jin Young Jung is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit specific enzymes related to various health conditions. With a total of 6 patents to his name, Jung's work is recognized for its potential impact on therapeutic applications.

Latest Patents

Among his latest patents, Jung has developed an amide derivative that serves as a diacylglycerol acyltransferase 2 (DGAT2) inhibitor. This invention relates to a compound that exhibits the activity of a DGAT2 inhibitor and is represented by a specific chemical formula. Additionally, he has patented a novel amino aryl derivative that is also useful as a DGAT2 inhibitor, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Jin Young Jung has worked with notable companies in the industry, including LG Chem, Ltd and Trinno Technology Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in pharmaceutical chemistry.

Collaborations

Throughout his career, Jung has collaborated with talented individuals such as Bo Kyung Seo and Su Young Yoon. These partnerships have fostered a creative environment that has led to the successful development of his patented inventions.

Conclusion

Jin Young Jung is a distinguished inventor whose work in pharmaceutical chemistry continues to influence the field. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.